Jonathan P. Mow
2020
In 2020, Jonathan P. Mow earned a total compensation of $1.8M as Chief Executive Officer at PhaseBio Pharmaceuticals, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $273,300 |
|---|---|
| Option Awards | $951,200 |
| Salary | $529,317 |
| Other | $9,819 |
| Total | $1,763,636 |
Mow received $951.2K in option awards, accounting for 54% of the total pay in 2020.
Mow also received $273.3K in non-equity incentive plan, $529.3K in salary and $9.8K in other compensation.
Rankings
In 2020, Jonathan P. Mow's compensation ranked 6,098th out of 13,090 executives tracked by ExecPay. In other words, Mow earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,098 out of 13,090 | 53rd |
Division Manufacturing | 2,517 out of 5,621 | 55th |
Major group Chemicals And Allied Products | 1,010 out of 2,254 | 55th |
Industry group Drugs | 875 out of 1,954 | 55th |
Industry Pharmaceutical Preparations | 653 out of 1,459 | 55th |
Source: SEC filing on April 22, 2022.
Mow's colleagues
We found two more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2020.